Drug intelligence / Profile preview

UX-DA002

Development stage
Unknown
Lead developer
UniXell Biotechnology
Modality
Allogeneic CAR-T → CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, CAR-NK Cells → Other Engineered Cells → Adoptive Cell Transfer → Cell Therapies, Allogeneic iPSCs → iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies
01

Overview

UX-DA002 is an investigational allogeneic cell therapy under development by UniXell Biotechnology. While detailed public information on the specific cell type, mechanism of action, or target indication for UX-DA002 is not yet available, it is described as a next-generation product following UX-DA001. Unlike the autologous iPSC-derived neural progenitor cell therapy (UX-DA001) for Parkinson’s disease, which uses a patient’s own cells, UX-DA002 utilizes donor-derived cells (allogeneic), potentially enabling off-the-shelf availability and broader clinical application. The drug has attracted regulatory interest and represents UniXell Biotechnology's continued efforts in innovative cell therapies[3].

Beyond the preview

Go deeper on UX-DA002.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UX-DA002.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call